Evolution of coronary stents in patients with diabetes: are clinical outcomes still improving?

Item

http://www.wikidata.org/entity/Q38221101

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Evolution of coronary stents i ...... ical outcomes still improving?

@en

type

Item

label

Evolution of coronary stents i ...... ical outcomes still improving?

@en

prefLabel

Evolution of coronary stents i ...... ical outcomes still improving?

@en

P1476

Evolution of coronary stents i ...... ical outcomes still improving?

@en

P2093

George Kassimis

http://www.w3.org/2001/XMLSchema#string

Niket Patel

http://www.w3.org/2001/XMLSchema#string

P2860

Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry

Long-term outcomes of biodegradable polymer versus durable polymer drug-eluting stents in patients with diabetes a pooled analysis of individual patient data from 3 randomized trials.

Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial.

Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis.

The association of diabetes mellitus with clinical outcomes after coronary stenting: a meta-analysis.

Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials.

Drug-eluting stent outcomes in diabetes.

Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial.

Comparison of everolimus-eluting and sirolimus-eluting coronary stents: 1-year outcomes from the Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting stent Trial (RESET).

Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System).

P304

997-1003

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14779072.2014.930664

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Giovanni Luigi De Maria

Adrian Banning

P577

2014-06-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24939631

http://www.w3.org/2001/XMLSchema#string